Pulse nav.journalClub トレンド探索質問研究者

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026プライバシーポリシー

ホーム探索 nav.journalClub トレンド

⌘+K

Mifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgery | Synapse

March 1, 2012Open Access

術前の子宮筋腫治療におけるミフェプリストン2.5 mgと5 mgの比較

Key Points

Key points are not available for this paper at this time.

Abstract

使用すべき用量は5 mgであるべきである。

Like

Bookmark

Share

View Full Paper

Cite This Study

Esteve et al.（木曜日）はこの問題を研究した。

synapsesocial.com/papers/69d7698fef4aa71f97f312a2 https://doi.org/https://doi.org/10.2147/ijwh.s28103

Like

Bookmark

Share

View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Mifepristone for the Treatment of Uterine Leiomyomas2008 · 93 citations
2Regression of Uterine Leiomyomata in Response to the Antiprogesterone RU 4861993 · 68 citations
3[A clinical control study on the treatment of uterine leiomyoma with gonadotrophin releasing hormone agonist or mifepristone].1998 · 29 citations
4Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissues.1980 · 178 citations
5Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study2010 · 123 citations